If you liked this article you might like

Biogen Stock Climbs After Goldman Adds to its 'Conviction Buy' List

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire

United Therapeutics, DOJ in Possible Settlement Over Drug Contributions